中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A practical synthesis of YZD-7082B, a novel orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of ER plus breast cancer

文献类型:期刊论文

作者He, Yongqi1,2; Leng, Xin-Yu1,3; Wang, Runying1,3; Sun, Lulu1; Zhang, Dan1; Yang, Yushe1,2,3
刊名MOLECULAR DIVERSITY
出版日期2025-03-16
页码12
关键词Suzuki coupling Hydrogenation Chiral resolution Reduction of amide Recrystallization
ISSN号1381-1991
DOI10.1007/s11030-025-11154-1
英文摘要In previous studies, we discovered YZD-7082B, a selective estrogen receptor degrader (SERD) with excellent comprehensive properties. Here, we reported the development of an efficient multigram-scale synthetic process for YZD-7082 in 13 steps. The route featured a chiral resolution of a thiochroman intermediate with a unique cis-1,2-diaryl motif using a chiral amine and a mild reduction of amide using ZnEt2/LiCl/(EtO)(3)SiH system. This approach also overcomes the issues of high loadings of palladium catalysts and long reaction time. The developed process provided YZD-7082B with an HPLC purity of > 99.8% and ee of > 99%.
WOS关键词REDUCTION ; AMIDES ; SECONDARY
资助项目Youth Innovation Promotion Association of Chinese Academy of Sciences[2021275]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:001446044900001
出版者SPRINGER
源URL[http://119.78.100.183/handle/2S10ELR8/316650]  
专题新药研究国家重点实验室
通讯作者Zhang, Dan; Yang, Yushe
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China
3.Univ Chinese Acad Sci, Sch Pharm, Beijing 100049, Peoples R China
推荐引用方式
GB/T 7714
He, Yongqi,Leng, Xin-Yu,Wang, Runying,et al. A practical synthesis of YZD-7082B, a novel orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of ER plus breast cancer[J]. MOLECULAR DIVERSITY,2025:12.
APA He, Yongqi,Leng, Xin-Yu,Wang, Runying,Sun, Lulu,Zhang, Dan,&Yang, Yushe.(2025).A practical synthesis of YZD-7082B, a novel orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of ER plus breast cancer.MOLECULAR DIVERSITY,12.
MLA He, Yongqi,et al."A practical synthesis of YZD-7082B, a novel orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of ER plus breast cancer".MOLECULAR DIVERSITY (2025):12.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。